Abacavir in combination with the inosine monophosphate dehydrogenase (IMPDH)-inhibitor mycophenolic acid is active against multidrug-resistant HIV-1 [1]

Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology

Volumn 22, Issue 4, 1999, Pages 406-407

  Heredia, A ^a   Margolis, D ^a   Oldach, D ^a   Hazen, R ^a   Le, N ^a   Redfield, R ^a  

^a UNIVERSITY OF MARYLAND   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ABACAVIR; INOSINATE DEHYDROGENASE; MYCOPHENOLIC ACID;

ANTIVIRAL ACTIVITY; DOSE RESPONSE; DRUG EFFECT; DRUG EFFICACY; ENZYME INHIBITION; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LETTER; MULTIDRUG RESISTANCE; PRIORITY JOURNAL;

ANTI-HIV AGENTS; DIDEOXYNUCLEOSIDES; DRUG RESISTANCE, MICROBIAL; DRUG RESISTANCE, MULTIPLE; DRUG THERAPY, COMBINATION; HIV INFECTIONS; HIV-1; HUMANS; IMP DEHYDROGENASE; MYCOPHENOLIC ACID; REVERSE TRANSCRIPTASE INHIBITORS;

EID: 0033403261     PISSN: 10779450     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Letter

References (10)